These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20881220)

  • 21. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Power analyses for longitudinal study designs with missing data.
    Tu XM; Zhang J; Kowalski J; Shults J; Feng C; Sun W; Tang W
    Stat Med; 2007 Jul; 26(15):2958-81. PubMed ID: 17154250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview.
    Atkinson AJ; Lalonde RL
    Clin Pharmacol Ther; 2007 Jul; 82(1):3-6. PubMed ID: 17571065
    [No Abstract]   [Full Text] [Related]  

  • 24. A semiparametric model for regression analysis of interval-censored failure time data.
    Finkelstein DM; Wolfe RA
    Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A latent-class mixture model for incomplete longitudinal Gaussian data.
    Beunckens C; Molenberghs G; Verbeke G; Mallinckrodt C
    Biometrics; 2008 Mar; 64(1):96-105. PubMed ID: 17608789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing treatment effects in unconfounded studies under model misspecification: logistic regression, discretization, and their combination.
    Cangul MZ; Chretien YR; Gutman R; Rubin DB
    Stat Med; 2009 Sep; 28(20):2531-51. PubMed ID: 19572258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gatekeeping procedures with clinical trial applications.
    Dmitrienko A; Tamhane AC
    Pharm Stat; 2007; 6(3):171-80. PubMed ID: 17583553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
    Liu GF; Lu K; Mogg R; Mallick M; Mehrotra DV
    Stat Med; 2009 Sep; 28(20):2509-30. PubMed ID: 19610129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling.
    Gieschke R; Reigner BG; Steimer JL
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):469-74. PubMed ID: 9352398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and recommendations on adaptive dose-ranging trials: highlights from the PhRMA Adaptive Dose-Ranging Studies Working Group.
    Pinheiro J
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):47S-49S. PubMed ID: 20881216
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of missing data in palliative care studies.
    Palmer JL
    J Pain Symptom Manage; 2004 Dec; 28(6):612-8. PubMed ID: 15589087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weibull prediction of event times in clinical trials.
    Ying GS; Heitjan DF
    Pharm Stat; 2008; 7(2):107-20. PubMed ID: 17377932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated methods for reporting clinical trials.
    Hait WN
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6753-4. PubMed ID: 16203758
    [No Abstract]   [Full Text] [Related]  

  • 37. Semiparametric regression analysis of longitudinal data with informative drop-outs.
    Lin DY; Ying Z
    Biostatistics; 2003 Jul; 4(3):385-98. PubMed ID: 12925506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A copula model for repeated measurements with non-ignorable non-monotone missing outcome.
    Shen C; Weissfeld L
    Stat Med; 2006 Jul; 25(14):2427-40. PubMed ID: 16143999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple testing for bioequivalence with pharmacokinetic data in 2 x 2 crossover designs.
    Chen YI; Huang CS
    Stat Med; 2009 Dec; 28(28):3567-79. PubMed ID: 19760611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Better design of drug-eluting stents using computer modeling.
    Park K
    J Control Release; 2009 Jan; 133(1):1. PubMed ID: 19038297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.